SCHEMBL15823673

SCHEMBL15823673

O=C(O)Nc1ccc(Br)cc1-c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.57
NPSR1 Q6W5P4 2/20 0.50
LMNA P02545 2/20 0.50
POLB P06746 1/20 0.50
PTGDR2 Q9Y5Y4 1/20 0.49
HIF1A Q16665 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
HTT P42858 1/20 0.47
AKR1C3 P42330 1/20 0.46
AKR1C2 P52895 1/20 0.46
AKR1C1 Q04828 1/20 0.46
MAPT P10636 3/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
TRPM2 O94759 1/20 0.44
CYP3A4 P08684 2/20 0.43
PTGFR P43088 1/20 0.43
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3907636 0.87 ALDH1A1 (0.51) ALDH1A1NPSR1LMNAPOLBPTGDR2
SCHEMBL99089 0.87 ALDH1A1 (0.56) ALDH1A1NPSR1LMNAPOLBPTGDR2
SCHEMBL30307389 0.87 ALDH1A1 (0.56) ALDH1A1NPSR1LMNAPOLBPTGDR2
SCHEMBL15823073 0.86 ALDH1A1 (0.54) ALDH1A1NPSR1LMNAPOLBPTGDR2
SCHEMBL4654120 0.81 ALDH1A1 (0.51) ALDH1A1NPSR1LMNAPOLBHTT
SCHEMBL5100217 0.81 HDAC7 (0.57) ALDH1A1LMNAPTGDR2MAPTNPC1
SCHEMBL23609707 0.81 MAPK1 (0.49) ALDH1A1NPSR1LMNAPOLBPTGDR2
SCHEMBL17796963 0.79 FABP4 (0.62) NPSR1PTGDR2RXFP1MAPTKMT2A
SCHEMBL27728897 0.79 CYP2C9 (0.50) ALDH1A1NPSR1LMNAPTGDR2HTT
SCHEMBL3906763 0.79 MAPT (0.56) ALDH1A1LMNAPOLBHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2934594-B1 CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES . ALMIRALL SA (ES) 2019-09-04 EP disclosed
EP-2934594-A1 NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY Almirall, S.A. (ES) 2015-10-28 EP disclosed
WO-2014095920-A1 NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY ALMIRALL, S.A. (ES) 2014-06-26 WO disclosed